Cxcr4 Rabbit Antibody Novus
Rabbit IgG Antibody |
|||
R20478-100UG | NSJ Bioreagents | 100ug | EUR 409 |
Human IgG antibody Laboratories manufactures the cxcr4 rabbit antibody novus reagents distributed by Genprice. The Cxcr4 Rabbit Antibody Novus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rabbit Antibody. Other Cxcr4 products are available in stock. Specificity: Cxcr4 Category: Rabbit Group: Antibody Novus
Rabbit IgG Fab Antibody |
||
NSJ Bioreagents | 250ug | EUR 832.15 |
Description: This recombinant Rabbit IgG Fab antibody reacts to the Fab region of Rabbit IgG. No cross reactivity with human/mouse/rat IgG. |
Rabbit IgG Fc Antibody |
||
NSJ Bioreagents | 100ug | EUR 339.15 |
Description: This recombinant Rabbit IgG Fc antibody reacts to the Fc region of Rabbit IgG. No cross reactivity with human/mouse/rat IgG. |
Rabbit IgG Fc Antibody |
||
NSJ Bioreagents | 50ug | EUR 339.15 |
Description: This recombinant Rabbit IgG Fc antibody reacts to the Fc region of Rabbit IgG. No cross reactivity with human IgG, rat IgG, or mouse IgG. |
Rabbit IgG Fc Antibody |
||
NSJ Bioreagents | 250ug | EUR 832.15 |
Description: This recombinant Rabbit IgG Fc antibody reacts to the Fc region of Rabbit IgG. No cross reactivity with human/mouse/rat IgG. |
Anti-Rabbit IgG antibody |
||
St John's Laboratory | 1 mg | EUR 256.8 |
Anti-Rabbit IgG antibody |
||
St John's Laboratory | 1.2 mg | EUR 308.4 |
Anti-Rabbit IgG antibody |
||
St John's Laboratory | 1.2 mg | EUR 367.2 |
CXCR4 Antibody |
|||
1012-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: CXCR4, a G-protein coupled receptor (GPCR) with seven transmembrane domains, is a CXC chemokine receptor specific for stromal-derived-factor-1 (SDF-1 or CXCL12). CXCR4 was initially discovered as one of the co-receptors for HIV entry into CD4+ T cells (1). Blocking CXCR4 could be potentially used as novel therapeutics for HIV treatment. CXCR4 signaling plays an important role in the migration, proliferation and quiescence of hematopoietic stem cell and their retention within the bone marrow, where it has high levels of SDF-1/CXCL12(2). It has been demonstrated that CXCR4 signaling mediates CD20 up-regulation on B cells (3). CXCR4 is highly expressed in more than 23 types of cancer, including breast cancer, ovarian cancer, melanoma, and prostate cancer, while there is very less or no expression of CXCR4 in healthy tissues. CXCR4 expression in cancer cells has been reported to be associated with tumor survival, growth and metastasis in tissues with high levels of SDF-1/CXCL12, such as lungs, liver and bone marrow (4,5). CXCR4 has been shown to regulate neuronal migration, cell positioning and axon wiring (6,7). CXCR4 mutant mice displayed aberrant neuronal distribution, which implicates the role in neuronal disorders such as epilepsy. CXCR4 is also involved in WHIM syndrome (8). WHIM mutations in CXCR4 were recently found in patients with Waldenstrom's macroglobulinemia, and these mutations are correlated to clinical resistance to ibrutinib (9,10). |
CXCR4 Antibody |
|||
1012-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: CXCR4, a G-protein coupled receptor (GPCR) with seven transmembrane domains, is a CXC chemokine receptor specific for stromal-derived-factor-1 (SDF-1 or CXCL12). CXCR4 was initially discovered as one of the co-receptors for HIV entry into CD4+ T cells (1). Blocking CXCR4 could be potentially used as novel therapeutics for HIV treatment. CXCR4 signaling plays an important role in the migration, proliferation and quiescence of hematopoietic stem cell and their retention within the bone marrow, where it has high levels of SDF-1/CXCL12(2). It has been demonstrated that CXCR4 signaling mediates CD20 up-regulation on B cells (3). CXCR4 is highly expressed in more than 23 types of cancer, including breast cancer, ovarian cancer, melanoma, and prostate cancer, while there is very less or no expression of CXCR4 in healthy tissues. CXCR4 expression in cancer cells has been reported to be associated with tumor survival, growth and metastasis in tissues with high levels of SDF-1/CXCL12, such as lungs, liver and bone marrow (4,5). CXCR4 has been shown to regulate neuronal migration, cell positioning and axon wiring (6,7). CXCR4 mutant mice displayed aberrant neuronal distribution, which implicates the role in neuronal disorders such as epilepsy. CXCR4 is also involved in WHIM syndrome (8). WHIM mutations in CXCR4 were recently found in patients with Waldenstrom's macroglobulinemia, and these mutations are correlated to clinical resistance to ibrutinib (9,10). |
CXCR4 Antibody |
|||
1009-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: CXCR4, a G-protein coupled receptor (GPCR) with seven transmembrane domains, is a CXC chemokine receptor specific for stromal-derived-factor-1 (SDF-1 or CXCL12). CXCR4 was initially discovered as one of the co-receptors for HIV entry into CD4+ T cells (1). Blocking CXCR4 could be potentially used as novel therapeutics for HIV treatment. CXCR4 signaling plays an important role in the migration, proliferation and quiescence of hematopoietic stem cell and their retention within the bone marrow, where it has high levels of SDF-1/CXCL12(2). It has been demonstrated that CXCR4 signaling mediates CD20 up-regulation on B cells (3). CXCR4 is highly expressed in more than 23 types of cancer, including breast cancer, ovarian cancer, melanoma, and prostate cancer, while there is very less or no expression of CXCR4 in healthy tissues. CXCR4 expression in cancer cells has been reported to be associated with tumor survival, growth and metastasis in tissues with high levels of SDF-1/CXCL12, such as lungs, liver and bone marrow (4,5). CXCR4 has been shown to regulate neuronal migration, cell positioning and axon wiring (6,7). CXCR4 mutant mice displayed aberrant neuronal distribution, which implicates the role in neuronal disorders such as epilepsy. CXCR4 is also involved in WHIM syndrome (8). WHIM mutations in CXCR4 were recently found in patients with Waldenstrom's macroglobulinemia, and these mutations are correlated to clinical resistance to ibrutinib (9,10). |
CXCR4 Antibody |
|||
1009-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: CXCR4, a G-protein coupled receptor (GPCR) with seven transmembrane domains, is a CXC chemokine receptor specific for stromal-derived-factor-1 (SDF-1 or CXCL12). CXCR4 was initially discovered as one of the co-receptors for HIV entry into CD4+ T cells (1). Blocking CXCR4 could be potentially used as novel therapeutics for HIV treatment. CXCR4 signaling plays an important role in the migration, proliferation and quiescence of hematopoietic stem cell and their retention within the bone marrow, where it has high levels of SDF-1/CXCL12(2). It has been demonstrated that CXCR4 signaling mediates CD20 up-regulation on B cells (3). CXCR4 is highly expressed in more than 23 types of cancer, including breast cancer, ovarian cancer, melanoma, and prostate cancer, while there is very less or no expression of CXCR4 in healthy tissues. CXCR4 expression in cancer cells has been reported to be associated with tumor survival, growth and metastasis in tissues with high levels of SDF-1/CXCL12, such as lungs, liver and bone marrow (4,5). CXCR4 has been shown to regulate neuronal migration, cell positioning and axon wiring (6,7). CXCR4 mutant mice displayed aberrant neuronal distribution, which implicates the role in neuronal disorders such as epilepsy. CXCR4 is also involved in WHIM syndrome (8). WHIM mutations in CXCR4 were recently found in patients with Waldenstrom's macroglobulinemia, and these mutations are correlated to clinical resistance to ibrutinib (9,10). |
CXCR4 antibody |
|||
20R-CG008 | Fitzgerald | 200 ug | EUR 651.6 |
Description: Goat polyclonal CXCR4 antibody |
CXCR4 Antibody |
|||
24002-100ul | SAB | 100ul | EUR 468 |
CXCR4 Antibody |
|||
24003-100ul | SAB | 100ul | EUR 468 |
CXCR4 antibody |
|||
20R-1808 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal CXCR4 antibody |
CXCR4 antibody |
|||
70R-30897 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal CXCR4 antibody |
CXCR4 antibody |
|||
70R-CR011 | Fitzgerald | 200 ug | EUR 522 |
Description: Affinity purified Rabbit polyclonal CXCR4 antibody |
CXCR4 Antibody |
|||
AF5279 | Affbiotech | 200ul | EUR 420 |
CXCR4 Antibody |
|||
AF6641 | Affbiotech | 100ul | EUR 420 |
CXCR4 Antibody |
|||
AF6642 | Affbiotech | 100ul | EUR 420 |
CXCR4 Antibody |
|||
5541-100 | Biovision | each | EUR 405.6 |
CXCR4 Antibody |
|||
5541-30T | Biovision | each | EUR 175.2 |
CXCR4 antibody |
|||
70R-12301 | Fitzgerald | 100 ug | EUR 536.4 |
Description: Rabbit polyclonal CXCR4 antibody |
CXCR4 antibody |
|||
70R-12359 | Fitzgerald | 100 ug | EUR 523.2 |
Description: Rabbit polyclonal CXCR4 antibody |